Showing 761-770 of 2740 results for "".
Advances in Devices for Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advances-in-devices-for-dermatology/18815/M. Christine Lee, MD provides an overview of some of the new and emerging laser technologies. She discusses advances in everything from lasers and light-based devices to radiofrequency, ultrasound, and combination devices for a variety of dermatologic issues including facial rejuvenation, vaginal reThe Evolving Paradigm in Treatment of Psoriasis
https://practicaldermatology.com/topics/psoriasis/the-evolving-paradigm-in-treatment-of-psoriasis/18640/Bruce Strober, MD, reviews the latest science in the management of psoriasis. Treatment strategies on the horizon may offer significantly improved efficacy with attractive dosing schedules, adding to the ability to help patients manage difficult skin and systemic implications of psoriasis, he said.Patient Surveys: When and Why
https://practicaldermatology.com/topics/practice-management/patient-surveys-when-and-why/19112/Todd E. Schlesinger, MD, discusses the benefits of patient surveys and offers tips to get the most out of surveys. Sometimes negative survey responses offer value to the practice--if you use the feedback to improve. Coverage from Vegas Cosmetic Surgery 2014.On Mentorship, Open- Mindedness, and Fulfillment: A Chat with Dr. Peter Lio
https://practicaldermatology.com/youngmd-connect/wrap-ups/on-mentorship-open-mindedness-and-fulfillment-a-chat-with-dr-peter-lio/29892/Young MD Connect recently hosted a mentorship session with Dr. Peter Lio to learn from a practicing professional in the field of dermatology in a relaxed “Ask Me Anything” setting. Dr. Lio is a clinical assistant professor of dermatology and pediatrics at Northwestern University and the founding dirThe Case for JAK Inhibitors to Treat AD
https://practicaldermatology.com/topics/atopic-dermatitis/case-jak-inhibitors-treat-ad/27109/E. James Song, MD, FAAD, Director of Clinical Research and Co-Chief Medical Officer for Frontier Dermatology, discusses his presentation “JAK Inhibitors in Atopic Dermatitis” from the 2024 American Academy of Dermatology (AAD) Innovation Academy.Estrogen and Skin: What Can We Do
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/estrogen-and-skin-what-can-we-do/20123/There’s accumulated evidence that depletion of estrogen with age contributes to the visible signs of skin aging. But dermatologists haven’t had many treatment options—until now. Joel L. Cohen, MD addresses the latest developments in care for estrogen deficient skin.Clinical Conversations: MOA of JAK Inhibitors in Dermatology
https://practicaldermatology.com/series/jak-inhibitors-in-practice/clinical-conversations-moa-of-jak-inhibitors-in-dermatology/20096/JAK inhibitors have a range of potential applications in clinical dermatology. In the first video of this series, Brad Glick, DO and Raj Chovatiya, MD explain the mechanism of action of JAK inhibitors and explain how they may be used topically or systemically to treat skin diseases like atopic dermaAn Update on Neuromodulators and Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/an-update-on-neuromodulators-and-fillers/19983/Suneel Chilukuri, MD discusses daxibotulinumtoxinA and its potential for longer lasting results. He also reviews newly available fillers and specific options for various areas of the face. Plus, he talks about low-cost options and how he’s using devices like SkinPen.Managing Patients with Atypical Nevi and Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/managing-patients-with-atypical-nevi-and-melanoma/19982/Monitoring patients with several atypical nevi who are at high risk for melanoma is very challenging. Steven Q. Wang, MD offers tips for improving diagnostic accuracy and discusses the role of dermoscopy in detecting melanoma as well as non-melanoma skin cancers at much earlier rates.Scientifically Speaking: Botulinum Toxin Formulation and Testing
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-botulinum-toxin-formulation-and-testing/19832/Ever wonder about the differences in formulation and manufacture of botulinum neurotoxins? Curious about the trials that support approval? In this edition of Scientifically Speaking, Joel L. Cohen, MD gets the answers to these questions and more from Conor Gallagher, PhD, Head of Medical Affairs, Re